Double Medical Technology Inc is a China-based company mainly engaged in the production, research and development and sales of high-value medical consumables. The Company's main products include orthopedic trauma implant consumables, spinal implant consumables, joint implant consumables, sports medicine and neurosurgery implant consumables, minimally invasive surgery consumables, oral implant consumables and others. The Company is also engaged in the production of surgical tools, instruments and dressings. The Company mainly conducts its businesses in the domestic and overseas markets.

Employees

4,704

Sector

Medical Equipment, Supplies & Distribution

Calendar

Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
10/07/26	CN¥44.76	-0.47%	2,811,708
09/07/26	CN¥44.97	+3.78%	3,343,425
08/07/26	CN¥43.33	-1.81%	1,980,021
07/07/26	CN¥44.13	-4.42%	2,838,458
06/07/26	CN¥46.17	+1.76%	4,802,394

End-of-day quote Shenzhen S.E.

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shenzhen S.E. Other stock markets 10/07/2026			5-day change	1st Jan Change
44.76 ^CNY	-0.47%		-1.34%	-5.51%

07-01	Tranche Update on Double Medical Technology Inc.'s Equity Buyback Plan announced on May 21, 2026.	CI
05-27	Double Medical Technology Inc. Approves Cash Dividend on A Shares for the Year 2025, Payable on 07 July 2026	CI

Market Cap	18.3B 2.7B 2.36B 2.18B 2.01B 3.82B 257B 3.88B 26.01B 10.22B 127B 10.13B 9.91B 436B	P/E 2024	35.9x	P/E 2025	32.2x
Enterprise Value	16.86B 2.49B 2.18B 2.01B 1.85B 3.52B 237B 3.58B 23.97B 9.41B 117B 9.34B 9.13B 402B	EV / Sales 2024	5.49x	EV / Sales 2025	6.85x
Free-Float	17.16%	Yield 2024	1.62%	Yield 2025	1.27%

07-01	Tranche Update on Double Medical Technology Inc.'s Equity Buyback Plan announced on May 21, 2026.	CI
05-27	Double Medical Technology Inc. Approves Cash Dividend on A Shares for the Year 2025, Payable on 07 July 2026	CI
05-21	Double Medical Technology Inc. announces an Equity Buyback for CNY 260 million worth of its shares.	CI
05-19	Double Medical Technology Inc. authorizes a Buyback Plan.	CI
04-29	Double Medical Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-23	Double Medical Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-23	Double Medical Technology Inc. announces Annual dividend, payable on July 07, 2026	CI
01-27	Double Medical Technology Forecasts Up to 71% Jump in 2025 Profit	MT
28/10/25	Double Medical Technology Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
26/08/25	Double Medical Technology Inc's shareholder to unload stake	RE
22/08/25	Double Medical Technology's H1 Profit Jumps 77%, Operating Revenue Climbs 26%	MT
21/08/25	Double Medical Technology Inc. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
22/05/25	Double Medical Technology Inc. Approves Final Cash Dividend on A Shares for the Year 2024, Payable on 30 May 2025	CI

1 day	-0.47%
1 week	-1.34%
Current month	+7.13%
1 month	+7.49%
3 months	+3.28%
6 months	-12.56%
Current year	-5.51%

Double Medical Technology Inc. Stock

Stocks

002901

CNE1000032W7

Medical Equipment, Supplies & Distribution

Valuation: Double Medical Technology Inc.

Chart: Double Medical Technology Inc.

Latest news : Double Medical Technology Inc.

Press Releases: Double Medical Technology Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Double Medical Technology Inc.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

1 week	42.75	47.18
1 month	40.4	47.18
Current year	39.58	53.21
1 year	37	66.5
3 years	21.78	66.5
5 years	21.78	69.93
10 years	13.87	120.38

Manager	Title	Age	Since
Jiong Luo CEO	Chief Executive Officer	58	01/06/2011
Dan He Chen DFI	Director of Finance/CFO	46	30/08/2023
Dong Yang Ruan ADM	Chief Administrative Officer	53	23/11/2015

Director	Title	Age	Since
Zhi Xiong Lin CHM	Chairman	53	01/08/2004
Zhi Jun Lin BRD	Director/Board Member	51	01/05/2008
Jiong Luo BRD	Director/Board Member	58	07/04/2017

Date	Insider	Type	Main position	Quantity	% Market Cap.
13/08/24	Dan He Chen	Buy	Chief Financial Officer	1,000	0.0003%
07/11/23	Shao Jian Han	Sell	Chief Technology Officer	5,400	0.0015%
01/11/23	Dong Yang Ruan	Sell	Chief Administrative Officer	7,500	0.0021%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOUBLE MEDICAL TECHNOLOGY INC.	-0.47%	-1.34%	+22.30%	+45.04%	2.7B
STRYKER CORPORATION	+0.82%	+0.99%	-16.46%	+11.68%	126B
SMITH & NEPHEW PLC	+0.84%	+1.15%	-1.34%	-2.61%	12.9B
GLAUKOS CORPORATION	-1.52%	+2.95%	+43.33%	+115.86%	8.97B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.14%	-2.38%	-47.99%	-72.05%	3.98B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.61%	-7.70%	-14.72%	-20.20%	1.74B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.49%	-3.87%	-4.88%	-25.01%	1.61B
INSPIRE MEDICAL SYSTEMS, INC.	+0.47%	+10.24%	-62.83%	-83.35%	1.49B
ENOVIS CORPORATION	+2.10%	+14.44%	-28.35%	-60.00%	1.48B
Average	+0.83%	+1.73%	-12.33%	-10.07%	17.92B
Weighted average by Cap.	+0.75%	+1.13%	-12.46%	+12.57%

	2024	2025
Net sales	2.14B 315M 275M 254M 235M 445M 30.04B 453M 3.04B 1.19B 14.8B 1.18B 1.16B 50.87B	2.6B 384M 336M 309M 286M 542M 36.58B 551M 3.7B 1.45B 18.02B 1.44B 1.41B 61.96B
Net income	357M 52.62M 46.03M 42.46M 39.21M 74.4M 5.02B 75.66M 507M 199M 2.47B 198M 193M 8.5B	600M 88.44M 77.36M 71.35M 65.9M 125M 8.43B 127M 853M 335M 4.16B 332M 325M 14.28B
Net Debt	-863M -127M -111M -103M -94.84M -180M -12.14B -183M -1.23B -482M -5.98B -478M -467M -20.56B	-1.43B -211M -185M -171M -158M -299M -20.16B -304M -2.04B -800M -9.93B -794M -777M -34.15B